One third of Brits stockpile drugs

June 24, 2019
Sales and Marketing UK, medicine, pharma, pharmaceuticals, stockpiling

A third (33%) of brits stockpile medicines, according to new research from Co-op Health. One in three British people never …

novo_flag

European approval for Novo’s Esperoct in haemophilia A

June 21, 2019
Medical Communications, Sales and Marketing Esperoct, Novo Nordisk, haemophilia, pharma

The European Commission has awarded approval to Novo Nordiskโ€™s extended half-life factor VIII therapy Esperoct (turoctocog alfa pegol, N8-GP) for …

shutterstock_114045100

Sanofi to axe 466 R&D positions in Germany and France

June 21, 2019
Medical Communications, Research and Development, Sales and Marketing Sanofi, pharma

Sanofi has announced that plans to reorganise its research and development operations will result in the losses of 466 jobs …

shutterstock_235920349

GSK offers concessions ahead of planned venture with Pfizer

June 21, 2019
Medical Communications, Sales and Marketing GSK, Pfizer, pharma

The European Commission has said that GlaxoSmithKline has offered concessions to address concerns relating to the British multinationalโ€™s planned joint …

Alimera Sciences secures NICE recommendation for uveitis eye implant

June 21, 2019
Medical Communications, Sales and Marketing Alimera Sciences, NICE, UK, pharma, uveitis

Britainโ€™s cost effectiveness body NICE has recommended the use of the fluocinolone acetonide implant, a new treatment option for patients …

Catalent to purchase Italy manufacturing facility from BMS

June 20, 2019
Manufacturing and Production, Sales and Marketing BMS, Bristol-Myers Squibb, Cataletnt, pharma

Bristol-Myers Squibb has reached an agreement with Catalent for the latter to acquire its Anagni, Italy-based facility which specialises in …

800px-blausen_0704_parkinsonsdisease

Scientists at King’s College London identify early signs of Parkinson’s disease

June 20, 2019
Research and Development King's College London, Kings College London, Parkinson's disease, pharma, serotonin

Scientists at Kingโ€™s College London say they have identified the earliest signs of Parkinsonโ€™s disease in the brain โ€“ 15 …

gilead-sciences

Gilead signs deal with Nurix Therapeutics worth more than $2.3 billion

June 20, 2019
Business Services, Research and Development Gilead, Nurix Therapeutics, pharma, protiens

Gilead has signed a deal with San Francisco biotech Nurix Therapeutics โ€“ a company focused on developing drugs that control …

gsk_china_2_2_0_1

GSK launch sale of consumer healthcare brands

June 20, 2019
Business Services GSK, Pfizer, consumer health, pharma, portfolio

British multinational GlaxoSmithKline (GSK) has launched a sale of some of its consumer healthcare brands. The sale comes as GSK …

28246711066_52e38bc591_z

No-deal Brexit could cause shortages and higher prices, healthcare distributors warn

June 19, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, UK, brexit, distribution, pharma, supply chain

The Healthcare Distribution Association (HDA) has warned MPs that Britain could face shortages of medicines if it were to leave …

NICE recommends Amgen’s Blincyto in rare acute lymphoblastic leukaemia sub-population

June 19, 2019
Research and Development, Sales and Marketing Amgen, Cancer, NICE, acute lymphoblastic leukaemia, blincyto, pharma

Patients on the NHS in England and Wales will now be able to access Amgenโ€™s Blincyto (blinatumomab) after NICE reveals …

Contract manufacturing services industry set to grow at CAGR of 10.6% between 2017-2027

June 19, 2019
Research and Development EU, Europe, biopharma, contract manufacturing services, manufacturing, pharma

The biopharmaceutical contract manufacturing market is expected to grow at a compound annual growth rate (CAGR) of 10.6% between 2017 …

merck-keytruda

MSD’s Keytruda snatches up first approval in small cell lung cancer

June 19, 2019
Research and Development, Sales and Marketing Cancer, FDA, MSD, US, keytruda, lung cancer, pharma

MSD has revealed that its anti-PD-1 immunotherapy Keytruda (pembrolizumab) has been awarded marketing authorisation from the FDA as a monotherapy …

european_commission_web_5

EU pharmaceutical industry lost โ‚ฌ16.5 billion in sales as staff shift to patent infringing firms

June 19, 2019
Research and Development EU, counterfeit, generics, pharma, sales

A report from the European Union Intellectual Property Office (EUIPO) has said โ€˜counterfeitโ€™ drugs cost the EU pharmaceutical industry โ‚ฌ16.5 …

16792957331_d9572dbdf4_z

FDA expand Paragraph IV Patent Certifications List for generic drugmakers

June 19, 2019
Research and Development FDA, Hatch-Waxman act, generic drugs, generics, pharma

The FDA has said that it is expanding a database used by generic drugmakers to get information on when their …

lynparza

EU approval for MSD and AZ’s Lynparza in first-line BRCA-mutated advanced ovarian cancer

June 18, 2019
Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, MSD, lynparza, ovarian cancer, pharma

AstraZeneca and MSDโ€™s jointly-developed therapy Lynparza (olaparib) has scored its third EU approval, the pair announced, with authorisation for the …

Roche secures world first with Japanese Rozlytrek approval in advanced recurrent solid tumours

June 18, 2019
Manufacturing and Production, Sales and Marketing Cancer, Japan, Roche, Rozlytrek, pharma

Rocheโ€™s personalised cancer therapy Rozlytrek (entrectinib) has seen its first approval: the drug has been approved in Japan for the …

800px-paracetamol_acetaminophen_500_mg_pills

MHRA recall M&A Pharmachem’s paracetamol due to fungal contamination

June 18, 2019
Manufacturing and Production Contamination, MHRA, fungal, paracetamol, pharma

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a recall of M&A Pharmachemโ€™s 500mg paracetamol tablets. The …

novo_flag

FDA approves Novo Nordisk’s Victoza for children with type 2 diabetes

June 18, 2019
Manufacturing and Production GLP-1, Novo Nordisk, Victoza, diabetes, liraglutide

The FDA has approved Novo Nordiskโ€™s Victoza (liraglutide) for paediatric patients aged 10 years and older with type 2 diabetes. …

The Gateway to Local Adoption Series

Latest content